This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a fluorine and trifluoromethyl group, makes it valuable in the development of drugs targeting specific receptors or enzymes, particularly in the central nervous system. It is often employed in the preparation of compounds with potential therapeutic applications, such as treatments for neurological disorders or pain management. Additionally, its chiral center allows for the creation of enantiomerically pure substances, which are crucial for ensuring the efficacy and safety of pharmaceutical products. Researchers also explore its use in medicinal chemistry for designing novel molecules with enhanced bioavailability and metabolic stability.